MEDICINOVA, INC. Debt Instrument, Interest Rate, Stated Percentage
MEDICINOVA, INC. (MNOV) had Debt Instrument, Interest Rate, Stated Percentage of 12.87% as of 2010-05-31, per its 10-K filed 2013-03-28.
Discontinued › Notes › Debt Instruments
us-gaap:DebtInstrumentInterestRateStatedPercentage · last filed 2013-03-28
- 2010-05-31: Debt Instrument, Interest Rate, Stated Percentage 12.87%.
| Period end | Debt Instrument, Interest Rate, Stated Percentage |
|---|---|
| 2010-05-31 | 12.87% 10-K · filed 2013-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |